Ozmosi | Bendazol Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Bendazol

Alternative Names: bendazol
Clinical Status: Inactive
Latest Update: 2024-02-26
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action:

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Brazil | China | Pakistan | Russia | Taiwan | Ukraine

Approved Indications: None

Known Adverse Events: None

Company: Ineye Hospital of Chengdu University of Traditional Chinese Medicine
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ChiCTR2300077773

 ChiCTR2300077773

N/A

Not yet recruiting

Myopia

2024-06-01

2023-11-21

Treatments

ChiCTR2500096603

 ChiCTR2500096603

N/A

/Completed

Myopia

2023-09-30

Recent News Events

Date

Type

Title

02/26/2024

PubMed

 Improved and ligand-free copper-catalyzed cyclization for an efficient synthesis of benzimidazoles from o-bromoarylamine and nitriles.

09/01/2020

PubMed

 Topical bendazol inhibits experimental myopia progression and decreases the ocular accumulation of HIF-1alpha protein in young rabbits.

01/01/2020

PubMed

 Base-deactivated and alkaline-resistant chromatographic stationary phase based on functionalized polymethylsilsesquioxane microspheres.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions